Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2002 16
2003 14
2004 6
2005 16
2006 11
2007 21
2008 16
2009 8
2010 9
2011 18
2012 17
2013 15
2014 12
2015 12
2016 21
2017 30
2018 34
2019 32
2020 36
2021 41
2022 33
2023 33
2024 45
2025 48
2026 32

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

510 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis.
Blockmans D, Penn SK, Setty AR, Schmidt WA, Rubbert-Roth A, Hauge EM, Keen HI, Ishii T, Khalidi N, Dejaco C, Cid MC, Hellmich B, Liu M, Zhao W, Lagunes I, Romero AB, Wung PK, Merkel PA; SELECT-GCA Study Group. Blockmans D, et al. N Engl J Med. 2025 May 29;392(20):2013-2024. doi: 10.1056/NEJMoa2413449. Epub 2025 Apr 2. N Engl J Med. 2025. PMID: 40174237 Clinical Trial.
The Gut-Kidney Axis in Chronic Kidney Diseases.
Tsuji K, Uchida N, Nakanoh H, Fukushima K, Haraguchi S, Kitamura S, Wada J. Tsuji K, et al. Among authors: wada j. Diagnostics (Basel). 2024 Dec 25;15(1):21. doi: 10.3390/diagnostics15010021. Diagnostics (Basel). 2024. PMID: 39795549 Free PMC article. Review.
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial.
Perkovic V, Trimarchi H, Tesar V, Lafayette R, Wong MG, Barratt J, Suzuki Y, Liew A, Zhang H, Carroll K, Jha V, Quevedo A, Han SH, Praga M, Chacko B, Sahay M, Cheung CK, Kooienga L, Walsh M, Xia J, Fajardo C, Shah L, Hafkin J, Rizk DV; VISIONARY Trial Investigators Group. Perkovic V, et al. N Engl J Med. 2026 Feb 12;394(7):635-646. doi: 10.1056/NEJMoa2512133. Epub 2025 Nov 8. N Engl J Med. 2026. PMID: 41211929 Clinical Trial.
Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice.
Suda M, Shimizu I, Katsuumi G, Yoshida Y, Hayashi Y, Ikegami R, Matsumoto N, Yoshida Y, Mikawa R, Katayama A, Wada J, Seki M, Suzuki Y, Iwama A, Nakagami H, Nagasawa A, Morishita R, Sugimoto M, Okuda S, Tsuchida M, Ozaki K, Nakanishi-Matsui M, Minamino T. Suda M, et al. Among authors: wada j. Nat Aging. 2021 Dec;1(12):1117-1126. doi: 10.1038/s43587-021-00151-2. Epub 2021 Dec 10. Nat Aging. 2021. PMID: 37117524
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Mayne KJ, Sardell RJ, Staplin N, Judge PK, Zhu D, Sammons E, Cherney DZI, Cheung AK, Maggioni AP, Nangaku M, Rossello X, Tuttle KR, Ihara K, Iwata T, Wanner C, Emberson J, Preiss D, Landray MJ, Baigent C, Haynes R, Herrington WG; EMPA-KIDNEY Collaborative Group. Mayne KJ, et al. Clin J Am Soc Nephrol. 2024 Sep 1;19(9):1119-1129. doi: 10.2215/CJN.0000000000000498. Epub 2024 Jun 27. Clin J Am Soc Nephrol. 2024. PMID: 40179340 Free PMC article. Clinical Trial.
Takayasu phlebitis.
Katayama Y, Matsumoto Y, Yamamura Y, Asano Y, Hayashi K, Ohashi K, Morishita M, Watanabe H, Narazaki M, Sada KE, Wada J. Katayama Y, et al. Among authors: wada j. Rheumatology (Oxford). 2020 Dec 1;59(12):e131-e133. doi: 10.1093/rheumatology/keaa333. Rheumatology (Oxford). 2020. PMID: 32617559 No abstract available.
Dotinurad Treatment for Patients With Hyperuricemia Complicating CKD.
Tanabe K, Nunoue T, Itabashi N, Katayama A, Nakamura A, Ohbayashi H, Onishi Y, Watanabe K, Maruyama K, Hosoya T, Okada S, Wada J; DTN-CKD Investigators. Tanabe K, et al. Among authors: wada j. Kidney Int Rep. 2025 Apr 3;10(6):1711-1720. doi: 10.1016/j.ekir.2025.03.047. eCollection 2025 Jun. Kidney Int Rep. 2025. PMID: 40630278 Free PMC article.
NDUFS4 regulates cristae remodeling in diabetic kidney disease.
Mise K, Long J, Galvan DL, Ye Z, Fan G, Sharma R, Serysheva II, Moore TI, Jeter CR, Anna Zal M, Araki M, Wada J, Schumacker PT, Chang BH, Danesh FR. Mise K, et al. Among authors: wada j. Nat Commun. 2024 Mar 4;15(1):1965. doi: 10.1038/s41467-024-46366-w. Nat Commun. 2024. PMID: 38438382 Free PMC article.
Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Heerspink HJL, Jardine MJ, Kohan DE, Lafayette R, Levin A, Liew A, Zhang H, Noronha IL, Mastroianni-Kirsztajn G, Chow S, Choi DE, Lv J, Trimarchi H, Fu P, Guenther S, Yang S, Liu J, Rahalkar S, Lodha A, Dahlke M, Kollins D, Barratt J; ALIGN study group. Heerspink HJL, et al. Lancet. 2026 Jun 13;407(10546):2387-2401. doi: 10.1016/S0140-6736(26)00960-8. Epub 2026 Jun 4. Lancet. 2026. PMID: 42242268 Clinical Trial.
510 results